accountsuch as heart attacks and strokes. A National Institutes of Health study released Thursday said high dosages of Abbott Laboratories' Niaspan failed to prevent heart attacks and boosted the likelihood of a stroke when combined with the popular generic...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Study casts doubt on effort to raise good cholesterol with Abbott drug
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account